Education
About Us
Working with TipRanks
Follow Us
Paul Sekhri Insider Profile
11 Followers
Paul Sekhri, Director at Veeva Systems, holds 16.34K shares in Veeva Systems (Ticker: VEEV), holds ― shares in Alpine Immune Sciences (Ticker: ALPN), holds 12.50K shares in BiomX (Ticker: PHGE).
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-43.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paul Sekhri holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul Sekhri
Paul Sekhri's Trading History
Veeva Systems
Mar 03, 2025
Director
Uninformative Buy
73.52K
$4.03M
Alpine Immune Sciences
―
―
―
―
BiomX
Jul 30, 2021
Director
Informative Buy
50.00K
$7.49K
Axcella Health
―
―
―
―
Longboard Pharmaceuticals
―
―
―
―
vTv Therapeutics
Nov 19, 2024
Pres, CEO and Exec Chairperson, Director
Uninformative Buy
83.78K
$76.95K
Enumeral Biomedical
―
―
―
$0.00
Ariad
―
―
―
$0.00
Albireo Pharma
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Paul Sekhri's performance on stock
You May Also Like
Paul Sekhri insider profile FAQ
What is the percentage of profitable transactions made by Paul Sekhri?
The percentage of profitable transactions made by Paul Sekhri is 33%.
What is the average return per transaction made by Paul Sekhri?
The average return per transaction made by Paul Sekhri is -43.60%.
What stocks does Paul Sekhri hold?
Paul Sekhri holds: VEEV, ALPN, PHGE, AXLA, LBPH, VTVT, ENUMQ, ARIA, ALBO stocks.
What was Paul Sekhri’s latest transaction?
Paul Sekhri latest transaction was an Uninformative Buy of $73.52K.
What was Paul Sekhri's most profitable transaction?
Paul Sekhri’s most profitable transaction was an Informative Sell of VEEV stock on June 21, 2021. The return on the trade was 39.80%.
What is Paul Sekhri's role in Veeva Systems?
Paul Sekhri's role in Veeva Systems is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.